KP Tissue (TSE:KPT) Posts Earnings Results

KP Tissue (TSE:KPT) announced its quarterly earnings results on Wednesday. The company reported C$0.26 earnings per share for the quarter, FiscalAI reports.

Here are the key takeaways from KP Tissue’s conference call:

• Adjusted EBITDA rose 26% YoY to CAD 84.2M in Q4 (revenue CAD 560.1M) and the company returned to positive net income of CAD 23.4M versus a loss a year ago.
• Kruger reported sustained market-share gains in Canada (facial tissue up 130 bps to 46.3%, paper towel up 130 bps to 25.3%) and says the U.S. is its key growth engine with continued distribution wins.
• Operational progress and capacity moves — Sherbrooke insourcing improved AFH margins, a new Memphis converting line is on track for early Q2 2026 startup, and management expects to announce details for a Western U.S. TAD plant (slated for 2028) in H1 2026.
• Management raised 2026 CapEx to CAD 100–120M (includes initial TAD spend), warns pulp prices may rise in 2026, and expects leverage could temporarily rise toward the mid‑4x range during construction — a potential short‑term headwind to shareholder returns.

KP Tissue Price Performance

KPT stock opened at C$10.68 on Thursday. KP Tissue has a 1 year low of C$7.54 and a 1 year high of C$10.68. The company has a market cap of C$106.52 million, a P/E ratio of 27.38, a price-to-earnings-growth ratio of -0.88 and a beta of 0.33. The stock’s fifty day moving average price is C$10.32 and its 200-day moving average price is C$9.85.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Canadian Imperial Bank of Commerce lifted their target price on KP Tissue from C$10.50 to C$11.00 in a report on Friday, November 14th. National Bank Financial lifted their price objective on KP Tissue from C$10.00 to C$11.00 and gave the stock a “sector perform” rating in a report on Monday, February 2nd. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of C$10.25.

Insider Buying and Selling

In other KP Tissue news, Director Michel Manseau sold 3,000 shares of the business’s stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of C$10.41, for a total transaction of C$31,230.00. Company insiders own 0.14% of the company’s stock.

KP Tissue Company Profile

KP Tissue Inc operates as a holding company. The firm produces, distributes, markets, and sells a range of disposable tissue products in North America. It offers bathroom and facial tissues, paper towels, paper towels, and napkins, as well as disposable wiping products and washroom dispensing systems.